Members of the Center conduct empiric economic analyses including evaluation and cost-effectiveness analyses of specific cancer treatments and discrete choice experiments. Additionally, members utilize decision modeling to support policy analyses and develop payment mechanism models (e.g. outcomes-based contracting).
Parker C, Woods B, Eaton J, Ma E, Selby R, Benson E, Engstrom A, Sajosi P, Briggs A, Bonthapally V. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in Scotland. J Med Econ. 2017 Jan;20(1):8-18. Epub 2016 Aug 11.